1. Optimizing dendritic cell–based anticancer immunotherapy: maturation state does have clinical impact

   • Dorian McIlroy
   • Marc Gregoire

   Review 24 June 2003 Pages: 583 - 591

2. Tumor immunotherapy by converting tumor cells to MHC class II–positive, Ii protein–negative phenotype

   • Xueqing Lu
   • Nikoletta L. Kallinteris
   • Minzhen Xu

   Original Article 19 June 2003 Pages: 592 - 598

   

3. Rapid turnover of the CD8⁺CD28^- T-cell subset of effector cells in the circulation of patients with head and neck cancer

   • Takashi Tsukishiro
   • Albert D. Donnenberg
   • Theresa L. Whiteside

   Original Article 19 June 2003 Pages: 599 - 607

   

4. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers

   • Govind Ragupathi
   • Fusataka Koide
   • Philip O. Livingston

   Original Article 17 June 2003 Pages: 608 - 616

   

5. Lymphocyte subsets and T _h 1/T _h 2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome

   • Johanna W. van Sandick
   • Marja A. Boermeester
   • J. Jan B. van Lanschot

   Original Article 12 June 2003 Pages: 617 - 624

   

6. The effects of αGalCer-induced TCRVα24 Vβ11⁺ natural killer T cells on NK cell cytotoxicity in umbilical cord blood

   • Yoko Ueda
   • Masao Hagihara
   • Tomomitsu Hotta

   Original Article 12 June 2003 Pages: 625 - 631

   

7. Tumor mRNA–loaded dendritic cells elicit tumor-specific CD8⁺ cytotoxic T cells in patients with malignant glioma

   • Tsutomu Kobayashi
   • Ryuya Yamanaka
   • Ryuichi Tanaka

   Original Article 21 June 2003 Pages: 632 - 637

   

8. Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients

   • L. G. Durrant
   • M. A. Chapman
   • N. C. Armitage

   Original Article 14 June 2003 Pages: 638 - 642

   

9. Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells

   • Laura Sanz
   • Mónica Feijóo
   • Luis Álvarez-Vallina

   Original Article 19 June 2003 Pages: 643 - 647

   

10. Development of Therapeutic Cancer Vaccines Conference, 27–29 April 2003

    • Margaret Marshall

    Symposium Series 13 August 2003 Pages: 648 - 654

11. Synopsis of the 5th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay

    • Malcolm S. Mitchell
    • W. Martin Kast

    Symposium Series 26 August 2003 Pages: 655 - 660